Adenovirus pneumonia complicated with acute respiratory distress syndrome: a case report

Ka-Ho Hung1, Lung-Huang Lin

  • 1From the Department of Pediatrics (K-HH, L-HL), Cathay General Hospital, Taipei; and School of Medicine (L-HL), Fu-Jen Catholic University, New Taipei City, Taiwan.

Medicine
|May 22, 2015
PubMed

Insights

Severe adenovirus pneumonia in children can cause acute respiratory distress syndrome (ARDS). Early extracorporeal membrane oxygenation (ECMO) with high-frequency oscillatory ventilation (HFOV) can be life-saving for pediatric ARDS patients.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Respiratory medicine

Background:

  • Severe adenovirus infection in children can lead to acute respiratory distress syndrome (ARDS) and respiratory failure.
  • Mechanical ventilation or extracorporeal life support (ECLS) may be required for prolonged periods.
  • Early extracorporeal membrane oxygenation (ECMO) intervention is recommended for pediatric ARDS patients meeting specific criteria.

Observation:

  • A 9-month-old boy with adenovirus pneumonia (serotype 7 confirmed) rapidly progressed to ARDS.
  • Conventional ARDS therapies were ineffective.
  • Chest X-rays showed progressive bilateral lung infiltrations and pleural effusions over 11 days.

Findings:

  • ECMO combined with high-frequency oscillatory ventilation (HFOV) was initiated for 9 days.
  • Gradual improvement in lung expansion was observed on chest X-rays.
  • The patient was discharged after 38 days, with outpatient follow-up for post-ECMO and adenovirus sequelae.

Implications:

  • Adenovirus pneumonia can cause significant pulmonary morbidity and respiratory failure in children.
  • The combination of HFOV for lung recruitment and ECMO for lung rest offers a viable therapeutic strategy for severe pediatric ARDS.
  • This case highlights the potential benefit of early ECMO and HFOV in managing severe adenovirus-induced ARDS in children.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...